Press release
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 2019-2025
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per 100,000 population respectively in 2015. Moreover, the CDC also estimates the incidence rate of types of IBD across the country. As per the CDC, the incidence of Crohn’s disease and ulcerative colitis were nearly 14.6 and 14.3 per 100,000 population respectively in 2015. Additionally, according to the aforementioned organization, the percentage of people diagnosed with IBD (either Crohn’s disease or ulcerative colitis) increased from 0.9% of US adults in 1999 to 1.3% of US adults in 2015. This percentage is further expected to expand in the near future; thereby, promising significant growth for the IBD market during the forecast period.A full report of US Inflammatory Bowel Disease (IBD) Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/us-ibd-inflammatory-bowel-disease-therapeutics-market
US IBD therapeutics market is segmented on the basis of disease type and treatment type. The disease type segment includes ulcerative colitis and Crohn’s disease. Crohn’s disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn’s disease than ulcerative colitis. For Crohn’s and ulcerative colitis, the development of minimally invasive methods has been evolved with more caution as compared to other colorectal diseases. This is primarily due to disease-related characteristics that are concerned with IBD. The treatment type segment is further segmented into anti-inflammatory drugs and surgery. There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressants (methotrexate, ciclosporin, and azathioprine), steroids and biological drugs. These are usually the first step in the treatment of IBD.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/us-ibd-inflammatory-bowel-disease-therapeutics-market
The companies which are contributing to the growth of the US IBD therapeutics market include Abbott Laboratories, AbbVie Inc., Celgene Corp., Eli Lilly and Co., Johnson & Johnson Services Inc., Laboratory Corporation of America Holdings, Pfizer Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.
US Inflammatory Bowel Disease (IBD) Therapeutics Market- Segmentation
By Disease Type
• Ulcerative Colitis
• Crohn’s Disease
By Treatment Type
• Surgery
• Anti- Inflammatory Drug Administration
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/us-ibd-inflammatory-bowel-disease-therapeutics-market
Company Profiles
• Abbott Laboratories
• AbbVie Inc.
• Boehringer Ingelheim International GmbH
• Celgene Corp.
• Eli Lilly and Co.
• Johnson & Johnson Services Inc.
• Laboratory Corporation of America Holdings
• Pfizer Inc.
• Sanofi S.A.
• Takeda pharmaceutical Co., Ltd.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 2019-2025 here
News-ID: 2150109 • Views: …
More Releases from Orion Market Research
GMP Testing Service Market Size Future Scope, Demands and Projected Industry Gro …
The GMP Testing Service Market was valued at approximately USD 2.5 billion in 2024 and is projected to reach around USD 5.8 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2033.
GMP Testing Service Market Overview:
The GMP Testing Service Market is experiencing robust growth driven by increasing regulatory requirements and the need for quality assurance in pharmaceutical and biotechnology industries. Good Manufacturing Practice…
Patient Registry Software Market Size Analysis, Competitive Insights, Leading Pl …
The Patient Registry Software Market was valued at approximately USD 700 million in 2024 and is anticipated to reach around USD 1.8 billion by 2033, growing at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2033.
Patient Registry Software Market Overview:
The Patient Registry Software Market is expanding rapidly as healthcare providers increasingly adopt digital solutions to collect, manage, and analyze patient data for improved clinical outcomes. These software…
Automotive Film Market Analysis Current Landscape and Future Outlook
The Automotive Film Market was valued at approximately USD 2.1 billion in 2024 and is projected to reach around USD 4.3 billion by 2033, growing at a compound annual growth rate (CAGR) of 8.2% from 2025 to 2033.
Automotive film Market Overview:
The Automotive Film Market is growing steadily as consumers and manufacturers increasingly prioritize vehicle aesthetics, UV protection, and heat insulation. These films are widely used for window tinting, paint…
Cold Chain Monitoring Market Size Unlocking New Opportunities for Success
The Cold Chain Monitoring Market was valued at approximately USD 3.8 billion in 2024 and is expected to reach around USD 9.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 11.4% from 2025 to 2033.
Cold Chain Monitoring Market Overview:
The Cold Chain Monitoring Market is witnessing significant growth driven by the increasing need to maintain product integrity across pharmaceutical, food, and chemical industries. Effective monitoring solutions help…
More Releases for IBD
Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 20 …
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn’s disease,…
Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios.
Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx…
France Inflammatory Bowel Disease (IBD) Therapeutics Market Size, Growth and For …
France IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.6% during the forecast period. The growing IBD patient population is one of the major driving forces for the growth of the market in the country. According to the National Institutes of, Health, the total number of cases associated with Crohn's disease in France were registered to be around 72,522 in 2017. This signifies the opportunity…
Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & For …
The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn's disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex and…
Canada Inflammatory Bowel Disease (IBD) Market Share, Size & Forecast to 2025
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn's disease,…
Indian IBD Therapeutics Market Growth, Opportunity, Size, Share and Forecast 201 …
Indian IBD therapeutics market is estimated to grow significantly at a CAGR of around 6.2% during the forecast period. The Indian pharmaceutical industry has been consistently growing with the public and private investments, making India as a potential market for the treatment of prevailing diseases such as IBD. Additionally, healthcare expenditure is playing a critical role in fueling the IBD therapeutics market in India.
Request a Free Sample of our…
